KALA BIO Settles $10.6M Debt for $2M, Eliminating Significant Financial Obligation
KALA sits 22% above its 52-week low of $0.51 on light trading volume (0.1× avg).
Summary
KALA BIO, Inc. has successfully settled a $10.6 million loan agreement with Oxford Finance, LLC for a payment of $2 million, significantly reducing its liabilities.
Key Events · Financing and Capital Events · KALA
-
Debt Settlement Completed
KALA BIO paid Oxford Finance, LLC $2 million on December 26, 2025, as per a previously disclosed Loan Settlement Agreement.
-
Significant Liability Reduction
This payment satisfied all obligations under the Settlement Agreement and the original Loan Agreement, settling an aggregate liability of approximately $10.6 million.
-
Improved Financial Position
The settlement effectively reduced the company's total liabilities by $8.6 million, removing a substantial financial burden.
Analysis · KALA · Life Sciences
This 8-K filing reports a highly material financial event for KALA BIO. By settling a $10.6 million debt for a $2 million payment, the company has effectively reduced its liabilities by $8.6 million. This substantial debt reduction significantly improves its balance sheet and removes a major financial overhang. For a micro-cap company, eliminating such a large obligation can be a critical step towards financial stability and future growth, potentially attracting new investors or improving creditworthiness.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KALA was trading at $0.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.6M. The 52-week trading range was $0.51 to $20.60. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.